Case Report
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Dec 26, 2021; 9(36): 11338-11345
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11338
Mucormycosis – resurgence of a deadly opportunist during COVID-19 pandemic: Four case reports
Shalini Upadhyay, Tanisha Bharara, Manisha Khandait, Ankit Chawdhry, Bharat Bhushan Sharma
Shalini Upadhyay, Tanisha Bharara, Manisha Khandait, Department ofMicrobiology, SGT University, Gurugram 122505, Haryana, India
Ankit Chawdhry, Department of Oral and Maxillofacial Surgery, SGT University, Gurugram 122505, Haryana, India
Bharat Bhushan Sharma, Department of Radiology, SGT University, Gurugram 122505, Haryana, India
Author contributions: Upadhyay S, Bharara T and Khandait M reviewed the literature and contributed to manuscript drafting; Upadhyay S, and Bharara T performed the microbiological analyses and interpretation; Chowdhry A was the oral and maxillofacial surgeon who took the history and performed detailed analysis of the cases; Sharma B analyzed and interpreted the imaging findings; Khandait M and Bharara T performed the revision of the manuscript for important intellectual content; all authors have read and approve the final manuscript.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Tanisha Bharara, MBBS, MD, Assistant Professor, Department of Microbiology, SGT University, Budhera Gurgaon, Gurugram 122505, Haryana, India. tanishabharara.med@gmail.com
Received: April 17, 2021
Peer-review started: April 17, 2021
First decision: July 15, 2021
Revised: August 6, 2021
Accepted: November 5, 2021
Article in press: November 5, 2021
Published online: December 26, 2021
Core Tip

Core Tip: Mucormycosis usually indicates a serious underlying medical condition such as diabetes. Furthermore, the immune dysregulation post coronavirus disease 2019, and widespread use of immunosuppressants and broad-spectrum antibiotics may lead to enhanced susceptibility to a number of secondary opportunistic infections such as mucormycosis. Clinical suspicion along with prompt microbiological diagnosis are indispensable to a positive case outcome.